These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 28866620)

  • 1. Hepatic Hippo signaling inhibits protumoural microenvironment to suppress hepatocellular carcinoma.
    Kim W; Khan SK; Liu Y; Xu R; Park O; He Y; Cha B; Gao B; Yang Y
    Gut; 2018 Sep; 67(9):1692-1703. PubMed ID: 28866620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hippo signaling interactions with Wnt/β-catenin and Notch signaling repress liver tumorigenesis.
    Kim W; Khan SK; Gvozdenovic-Jeremic J; Kim Y; Dahlman J; Kim H; Park O; Ishitani T; Jho EH; Gao B; Yang Y
    J Clin Invest; 2017 Jan; 127(1):137-152. PubMed ID: 27869648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic Hippo signaling inhibits development of hepatocellular carcinoma.
    Liu Y; Wang X; Yang Y
    Clin Mol Hepatol; 2020 Oct; 26(4):742-750. PubMed ID: 32981290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hippo/Yap signaling controls epithelial progenitor cell proliferation and differentiation in the embryonic and adult lung.
    Lange AW; Sridharan A; Xu Y; Stripp BR; Perl AK; Whitsett JA
    J Mol Cell Biol; 2015 Feb; 7(1):35-47. PubMed ID: 25480985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene.
    Zhou D; Conrad C; Xia F; Park JS; Payer B; Yin Y; Lauwers GY; Thasler W; Lee JT; Avruch J; Bardeesy N
    Cancer Cell; 2009 Nov; 16(5):425-38. PubMed ID: 19878874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interacting network of Hippo, Wnt/β-catenin and Notch signaling represses liver tumor formation.
    Kim W; Khan SK; Yang Y
    BMB Rep; 2017 Jan; 50(1):1-2. PubMed ID: 27881216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver.
    Lu L; Li Y; Kim SM; Bossuyt W; Liu P; Qiu Q; Wang Y; Halder G; Finegold MJ; Lee JS; Johnson RL
    Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1437-42. PubMed ID: 20080689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrin α2β1 inhibits MST1 kinase phosphorylation and activates Yes-associated protein oncogenic signaling in hepatocellular carcinoma.
    Wong KF; Liu AM; Hong W; Xu Z; Luk JM
    Oncotarget; 2016 Nov; 7(47):77683-77695. PubMed ID: 27765911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. S1P Stimulates Proliferation by Upregulating CTGF Expression through S1PR2-Mediated YAP Activation.
    Cheng JC; Wang EY; Yi Y; Thakur A; Tsai SH; Hoodless PA
    Mol Cancer Res; 2018 Oct; 16(10):1543-1555. PubMed ID: 29903770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A conserved MST1/2-YAP axis mediates Hippo signaling during lung growth.
    Lin C; Yao E; Chuang PT
    Dev Biol; 2015 Jul; 403(1):101-13. PubMed ID: 25912685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WWC2 is an independent prognostic factor and prevents invasion via Hippo signalling in hepatocellular carcinoma.
    Zhang Y; Yan S; Chen J; Gan C; Chen D; Li Y; Wen J; Kremerskothen J; Chen S; Zhang J; Cao Y
    J Cell Mol Med; 2017 Dec; 21(12):3718-3729. PubMed ID: 28815883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deregulation of Hippo kinase signalling in human hepatic malignancies.
    Li H; Wolfe A; Septer S; Edwards G; Zhong X; Abdulkarim AB; Ranganathan S; Apte U
    Liver Int; 2012 Jan; 32(1):38-47. PubMed ID: 22098159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. YAP Subcellular Localization and Hippo Pathway Transcriptome Analysis in Pediatric Hepatocellular Carcinoma.
    LaQuaglia MJ; Grijalva JL; Mueller KA; Perez-Atayde AR; Kim HB; Sadri-Vakili G; Vakili K
    Sci Rep; 2016 Sep; 6():30238. PubMed ID: 27605415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinal dehydrogenase 5 (RHD5) attenuates metastasis via regulating HIPPO/YAP signaling pathway in Hepatocellular Carcinoma.
    Hu H; Xu L; Luo SJ; Xiang T; Chen Y; Cao ZR; Zhang YJ; Mo Z; Wang Y; Meng DF; Yu L; Lin LZ; Zhang SJ
    Int J Med Sci; 2020; 17(13):1897-1908. PubMed ID: 32788868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression.
    Song H; Mak KK; Topol L; Yun K; Hu J; Garrett L; Chen Y; Park O; Chang J; Simpson RM; Wang CY; Gao B; Jiang J; Yang Y
    Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1431-6. PubMed ID: 20080598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tubule-Specific Mst1/2 Deficiency Induces CKD
    Xu C; Wang L; Zhang Y; Li W; Li J; Wang Y; Meng C; Qin J; Zheng ZH; Lan HY; Mak KK; Huang Y; Xia Y
    J Am Soc Nephrol; 2020 May; 31(5):946-961. PubMed ID: 32253273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SIRT7 promotes Hippo/YAP activation and cancer cell proliferation in hepatocellular carcinoma via suppressing MST1.
    Gu Y; Ding C; Yu T; Liu B; Tang W; Wang Z; Tang X; Liang G; Peng J; Zhang X; Li Z
    Cancer Sci; 2024 Apr; 115(4):1209-1223. PubMed ID: 38288904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of the hippo signaling pathway in human gastric cancer.
    Zhou GX; Li XY; Zhang Q; Zhao K; Zhang CP; Xue CH; Yang K; Tian ZB
    Asian Pac J Cancer Prev; 2013; 14(9):5199-205. PubMed ID: 24175801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ablation of high-mobility group box-1 in the liver reduces hepatocellular carcinoma but causes hyperbilirubinemia in Hippo signaling-deficient mice.
    Athavale D; Song Z; Desert R; Han H; Das S; Ge X; Komakula SSB; Chen W; Gao S; Lantvit D; Guzman G; Nieto N
    Hepatol Commun; 2022 Aug; 6(8):2155-2169. PubMed ID: 35344292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance.
    Zhou D; Zhang Y; Wu H; Barry E; Yin Y; Lawrence E; Dawson D; Willis JE; Markowitz SD; Camargo FD; Avruch J
    Proc Natl Acad Sci U S A; 2011 Dec; 108(49):E1312-20. PubMed ID: 22042863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.